Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms

被引:21
作者
Sharma, Akash [1 ]
Roy, Sweta [2 ]
Sharma, Ruchika [3 ]
Kumar, Anoop [1 ,2 ,4 ]
机构
[1] Delhi Pharmaceut Sci & Res Univ DPSRU, Dept Clin Res, New Delhi, India
[2] Delhi Pharmaceut Sci & Res Univ DPSRU, Dept Pharmacol, New Delhi, India
[3] Delhi Pharmaceut Sci & Res Univ DPSRU, Ctr Precis Med & Pharm, New Delhi, India
[4] Delhi Pharmaceut Sci & Res Univ DPSRU, Dept Pharmacol, Dept Clin Res, New Delhi 110017, India
关键词
antiviral drugs; data mining algorithms; docking study; DRESS;
D O I
10.1002/jmv.28671
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antiviral drugs are not known for drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The current study aims is to find out the association of antiviral drugs and their possible mechanism with DRESS. Data mining algorithms such as proportional reporting ratio that is, PRR (>= 2) with associated chi(2) value (>4), reporting odds ratio that is, ROR (>= 2) with 95% confidence interval and case count (>= 3) were calculated to identify a possible signal. Further, molecular docking studies were conducted to check the interaction of selected antiviral drugs with possible targets. The potential signal of DRESS was found to be associated with abacavir, acyclovir, ganciclovir, lamivudine, lopinavir, nevirapine, ribavirin, ritonavir, and zidovudine among all selected antiviral drugs. Further, subgroup analysis has also shown a potential signal in different age groups and gender. The sensitivity analysis results have shown a decrease in the strength of the signal, however, there was no significant impact on the outcome except for acyclovir. The docking results have indicated the possible involvement of human leukocyte antigen (HLA)*B1502 and HLA*B5801. The positive signal of DRESS was found with selected antiviral drugs except for acyclovir.
引用
收藏
页数:14
相关论文
共 27 条
[1]  
[Anonymous], Practical aspects of signal detection in pharmacovigilance
[2]   Treatment with Intravenous Acyclovir Desensitization for Severe Acyclovir Allergy: A Case of Herpes Encephalitis [J].
Arslan Gulen, Tugba ;
Ozden, Guzin ;
Turanc, Tuba .
MIKROBIYOLOJI BULTENI, 2022, 56 (02) :371-376
[3]   Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients [J].
Avancini, J. ;
Maragno, L. ;
Santi, C. G. ;
Criado, P. R. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (08) :851-859
[4]  
Bhosale Shailesh, 2021, Curr Res Pharmacol Drug Discov, V2, P100043, DOI 10.1016/j.crphar.2021.100043
[5]   OpenVigil FDA - Inspection of US American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications [J].
Boehm, Ruwen ;
von Hehn, Leocadie ;
Herdegen, Thomas ;
Klein, Hans-Joachim ;
Bruhn, Oliver ;
Petri, Holger ;
Hoecker, Jan .
PLOS ONE, 2016, 11 (06)
[6]   Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations [J].
Caster, Ola ;
Aoki, Yasunori ;
Gattepaille, Lucie M. ;
Grundmark, Birgitta .
DRUG SAFETY, 2020, 43 (05) :479-487
[7]  
Center for Drug Evaluation and Research, 2021, FDA Adverse Event Reporting System (FAERS) public dashboard
[8]   Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions - a prospective comparative study [J].
Chen, Y. -C. ;
Chiang, H. -H. ;
Cho, Y. -T. ;
Chang, C. -Y. ;
Chen, K. -L. ;
Yang, C. -W. ;
Lee, Y. -H. ;
Chu, C. -Y. .
ALLERGY, 2015, 70 (05) :568-575
[9]   Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections [J].
De Clercq, E ;
Neyts, J .
REVIEWS IN MEDICAL VIROLOGY, 2004, 14 (05) :289-300
[10]   Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study [J].
de Lucena Vieira, Jean Mendes ;
de Matos, Guacira Correa ;
Barbosa da Silva, Fabricio Alves ;
Bracken, Louise E. ;
Peak, Matthew ;
Lima, Elisangela da Costa .
FRONTIERS IN PHARMACOLOGY, 2020, 11